A Cross-Sectional Study Comparing the Prevalence of Bullous Pemphigoid Autoantibodies in 275 Cases of Type II Diabetes Mellitus Treated With or Without Dipeptidyl Peptidase-IV Inhibitors

Background: Anti-hyperglycemic drug dipeptidyl peptidase-IV inhibitors (DPP-4i) have recently been recognized as bullous pemphigoid (BP) inducing drugs. It remains uncertain whether DPP-4i induce BP-IgG autoantibodies before the onset of BP. Objective: To evaluate the effect of DPP-4i in the develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Izumi, Kentaro, Nishie, Wataru, Beniko, Mutsuo, Shimizu, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607930/
https://www.ncbi.nlm.nih.gov/pubmed/31297116
http://dx.doi.org/10.3389/fimmu.2019.01439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607930/
https://www.ncbi.nlm.nih.gov/pubmed/31297116
http://dx.doi.org/10.3389/fimmu.2019.01439

Ejemplares similares